The relationship between hormonal contraceptives, level of anxiety and emotional awareness: pilot project
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
39808178
PubMed Central
PMC11827054
DOI
10.33549/physiolres.935511
PII: 935511
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Emotions * drug effects MeSH
- Contraceptives, Oral, Hormonal * adverse effects MeSH
- Contraceptives, Oral, Combined * adverse effects MeSH
- Humans MeSH
- Menstrual Cycle drug effects psychology MeSH
- Adolescent MeSH
- Young Adult MeSH
- Pilot Projects MeSH
- Awareness * drug effects MeSH
- Anxiety * psychology chemically induced MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Contraceptives, Oral, Hormonal * MeSH
- Contraceptives, Oral, Combined * MeSH
An important part of the side effects of combined oral contraceptives (COC) usage is its psychological impact, which includes mood changes, anxiousness and depression. The psychological impacts are expected to be caused by physiological fluctuations of sex hormone levels during the menstrual cycle; this cycling is, however, suppressed in COC users. In our study, we assessed the differences in emotional awareness and anxiousness between women long term users of anti-androgenic COC (AA) and women with no COC use in their medical history (C). We also searched for intraindividual differences by comparing the results of both groups for the follicular and luteal phase of their cycle. A total of 45 women aged 18 to 22 participated in this study. The respondents were given our battery of questionnaires at the beginning of their follicular phase - this battery included two State-Trait Anxiety Inventory questionnaires (STAI-I, STAI-II), as well as a Levels of Emotional Awareness Scale (LEAS) test. The respondents were given only STAI-I in their luteal phase. We also analyzed the hormonal profile of our respondents. Our results show a significant difference in the LEAS analysis, implying the possibility of altered emotional awareness in AA group. STAI-I and STAI-II analysis did not yield any significant results, showing that anxiety levels of COC users probably do not differ from the general female population. We therefore discovered lower emotional awareness in COC using women (AA). Key words LEAS, STAI, Combined oral contraceptives, Anxiety, Hormonal profile.
See more in PubMed
Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, et al. Progesterone Receptors: Form and Function in Brain. Front Neuroendocrinol. 2008;29:313–339. doi: 10.1016/j.yfrne.2008.02.001. PubMed DOI PMC
Gu X, Hof PR, Friston KJ, Fan J. Anterior Insular Cortex and Emotional Awareness. J Comp Neurol. 2013;521:3371. doi: 10.1002/cne.23368. PubMed DOI PMC
Liu M, Zhang X, He Z, Liang Y, Zou B, Ma X, Gu S, Wang F. Opposite effects of estradiol and progesterone on woman’s disgust processing. Front Psychiatry. 2023;14:1161488. doi: 10.3389/fpsyt.2023.1161488. PubMed DOI PMC
Sakaki M, Mather M. How reward and emotional stimuli induce different reactions across the menstrual cycle. Soc Personal Psychol Compass. 2012;6:1–17. doi: 10.1111/j.1751-9004.2011.00415.x. PubMed DOI PMC
Wright AA, Fayad GN, Selgrade JF, Olufsen MS. Mechanistic model of hormonal contraception. PLoS Comput Biol. 2020;16:e1007848. doi: 10.1371/journal.pcbi.1007848. PubMed DOI PMC
Henckens MJ, van Wingen GA, Joëls M, Fernández G. Time-dependent effects of cortisol on selective attention and emotional interference: a functional MRI study. Front Integr Neurosci. 2012;6:66. doi: 10.3389/fnint.2012.00066. PubMed DOI PMC
Klusmann H, Luecking N, Engel S, Blecker MK, Knaevelsrud C, Schumacher S. Menstrual cycle-related changes in HPA axis reactivity to acute psychosocial and physiological stressors - A systematic review and meta-analysis of longitudinal studies. Neurosci Biobehav Rev. 2023;150:105212. doi: 10.1016/j.neubiorev.2023.105212. PubMed DOI
Schlotz W, Schulz P, Hellhammer J, Stone AA, Hellhammer DH. Trait anxiety moderates the impact of performance pressure on salivary cortisol in everyday life. Psychoneuroendocrinology. 2006;31:459–472. doi: 10.1016/j.psyneuen.2005.11.003. PubMed DOI
Oinonen KA, Mazmanian D. To what extent do oral contraceptives influence mood and affect? J Affect Disord. 2002;70:229–240. doi: 10.1016/S0165-0327(01)00356-1. PubMed DOI
Pletzer BA, Kerschbaum HH. 50 years of hormonal contraception-time to find out, what it does to our brain. Front Neurosci. 2014;8:256. doi: 10.3389/fnins.2014.00256. PubMed DOI PMC
Kanbara K, Fukunaga M. Links among emotional awareness, somatic awareness and autonomic homeostatic processing. Biopsychosoc Med. 2016;10:16. doi: 10.1186/s13030-016-0059-3. PubMed DOI PMC
Lane RD. Theory of emotional awareness and brain processing of emotion. Int Congr Ser. 2006;1287:116–121. doi: 10.1016/j.ics.2005.12.041. DOI
Laux L. Das State-Trait-Angstinventar (STAI): Theoretische Grundlagen und Handanweisung. Weinheim: Beltz; 1981. p. 75.
Spielberger C, Gorsuch R, Lushene R. Mannual for the State-Trait anxiety inventory STAI (Form) 1970
Baerwald AR, Pierson RA. Ovarian Follicular Development During the Use of Oral Contraception: A Review. J Obstet Gynaecol Can. 2004;26:19–24. doi: 10.1016/S1701-2163(16)30692-2. PubMed DOI PMC
Radke S, Derntl B. Affective responsiveness is influenced by intake of oral contraceptives. Eur Neuropsychopharmacol. 2016;26:1014–1019. doi: 10.1016/j.euroneuro.2016.03.004. PubMed DOI
Kimmig A-CS, Bischofberger JA, Birrenbach AD, Drotleff B, Lämmerhofer M, Sundström-Poromaa I, Derntl B. No Evidence for a Role of Oral Contraceptive-Use in Emotion Recognition But Higher Negativity Bias in Early Follicular Women. Front Behav Neurosci. 2022;15:773961. doi: 10.3389/fnbeh.2021.773961. PubMed DOI PMC
Hamstra DA, de Kloet ER, van Hemert AM, de Rijk RH, Van der Does AJW. Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing. Neuroscience. 2015;286:412–422. doi: 10.1016/j.neuroscience.2014.12.004. PubMed DOI
Pahnke R, Mau-Moeller A, Junge M, Wendt J, Weymar M, Hamm AO, Lischke A. Oral Contraceptives Impair Complex Emotion Recognition in Healthy Women. Front Neurosci. 2019;12:1041. doi: 10.3389/fnins.2018.01041. PubMed DOI PMC
Rapkin AJ, Biggio G, Concas A. Oral contraceptives and neuroactive steroids. Pharmacol Biochem Behav. 2006;84:628–634. doi: 10.1016/j.pbb.2006.06.008. PubMed DOI
Santoru F, Berretti R, Locci A, Porcu P, Concas A. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology (Berl) 2014;231:3351–3364. doi: 10.1007/s00213-014-3539-9. PubMed DOI
Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry. 2017;4:73–82. doi: 10.1016/S2215-0366(16)30358-3. PubMed DOI
Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, Nappi RE, et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab. 1998;83:2099–2103. doi: 10.1210/jcem.83.6.4905. PubMed DOI
Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, et al. Allopregnanolone and mood disorders. Prog Neurobiol. 2014;113:88–94. doi: 10.1016/j.pneurobio.2013.07.005. PubMed DOI
Kimball A, Dichtel LE, Nyer MB, Mischoulon D, Fisher LB, Cusin C, Dording CM, et al. The Allopregnanolone to Progesterone Ratio Across the Menstrual Cycle and in Menopause. Psychoneuroendocrinology. 2020;112:104512. doi: 10.1016/j.psyneuen.2019.104512. PubMed DOI PMC
Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213. doi: 10.1016/j.ynstr.2020.100213. PubMed DOI PMC
Hellgren C, Åkerud H, Skalkidou A, Bäckström T, Sundström-Poromaa I. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology. 2014;69:147–153. doi: 10.1159/000358838. PubMed DOI
Sundström-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone - Friend or foe? Front Neuroendocrinol. 2020;59:100856. doi: 10.1016/j.yfrne.2020.100856. PubMed DOI
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis. Psychosom Med. 1999;61:154. doi: 10.1097/00006842-199903000-00006. PubMed DOI
Hertel J, König J, Homuth G, Van der Auwera S, Wittfeld K, Pietzner M, et al. Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives. Sci Rep. 2017;7:14111. doi: 10.1038/s41598-017-13927-7. PubMed DOI PMC
Cunningham MG, Bhattacharyya S, Benes FM. Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J Comp Neurol. 2002;453:116–130. doi: 10.1002/cne.10376. PubMed DOI
Been LE, Sheppard PAS, Galea LAM, Glasper ER. Hormones and neuroplasticity: A lifetime of adaptive responses. Neurosci Biobehav Rev. 2022;132:679–690. doi: 10.1016/j.neubiorev.2021.11.029. PubMed DOI
Brønnick MK, Økland I, Graugaard C, Brønnick KK. The Effects of Hormonal Contraceptives on the Brain: A Systematic Review of Neuroimaging Studies. Front Psychol. 2020;11:556577. doi: 10.3389/fpsyg.2020.556577. PubMed DOI PMC
Chen KX, Worley S, Foster H, Edasery D, Roknsharifi S, Ifrah C, Lipton M. Oral contraceptive use is associated with smaller hypothalamic and pituitary gland volumes in healthy women: A structural MRI study. PLoS One. 2021;16:e0249482. doi: 10.1371/journal.pone.0249482. PubMed DOI PMC
Martell S, Marini C, Kondas CA, Deutch AB. Psychological side effects of hormonal contraception: a disconnect between patients and providers. Contracept Reprod Med. 2023;8:9. doi: 10.1186/s40834-022-00204-w. PubMed DOI PMC